Van Laere et al. demonstrated that activation of NF-kB in inflammatory breast cancer was associated with loss of ERα expression, suggesting ERα might play a positive role in anti-inflammation [56]. The gene discussed is NFKB1; the disease is inflammatory breast carcinoma.